AffyImmune Therapeutics
Natick, US · Founded 2016 · Delaware corporation · 1 known investors
Find your way into AffyImmune Therapeutics
Founders & leadership
GS
MJ
Moonsoo JinNamed on SEC filing
HF
Hong Fang SongNamed on SEC filing
Investors · 1
Funding
SEC filings, press & company announcements$7.9M disclosed across 1 of 2 rounds · 2018–2021
- Undisclosed amountSeries A+Oct 2021Source ↗
▶$7.9MraisedNov 2018 · 2 investors · Other TechnologyRule 506(b)
▶$7.9MraisedNov 2018 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Gang SongExecutive Officer, Director
- Moonsoo JinExecutive Officer, Director
- Hong Fang SongDirector
- Offering amount
- $14.6M
- Amount sold
- $7.9M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are AffyImmune Therapeutics's investors?
- AffyImmune Therapeutics's investors include ORI Capital.
- How much funding has AffyImmune Therapeutics raised?
- AffyImmune Therapeutics has disclosed $7.9M raised across 1 of its 2 known rounds.
- Where is AffyImmune Therapeutics headquartered?
- AffyImmune Therapeutics is headquartered in Natick, US.